141 related articles for article (PubMed ID: 30352834)
1. LncRNA BDNF-AS is associated with the malignant status and regulates cell proliferation and apoptosis in osteosarcoma.
Huang Q; Yang J; He X; Shi S; Xing S
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30352834
[TBL] [Abstract][Full Text] [Related]
2. LncRNA SOX2-OT is a novel prognostic biomarker for osteosarcoma patients and regulates osteosarcoma cells proliferation and motility through modulating SOX2.
Wang Z; Tan M; Chen G; Li Z; Lu X
IUBMB Life; 2017 Nov; 69(11):867-876. PubMed ID: 28960757
[TBL] [Abstract][Full Text] [Related]
3. LOXL1-AS1 predicts poor prognosis and promotes cell proliferation, migration, and invasion in osteosarcoma.
Chen S; Li W; Guo A
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30944201
[TBL] [Abstract][Full Text] [Related]
4. GAPLINC is a predictor of poor prognosis and regulates cell migration and invasion in osteosarcoma.
Liao S; Zhou S; Wang C
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30177521
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA XIST regulates PDCD4 expression by interacting with miR-21-5p and inhibits osteosarcoma cell growth and metastasis.
Zhang R; Xia T
Int J Oncol; 2017 Nov; 51(5):1460-1470. PubMed ID: 29048648
[TBL] [Abstract][Full Text] [Related]
6. LncRNA CBR3-AS1 predicts unfavorable prognosis and promotes tumorigenesis in osteosarcoma.
Zhang Y; Meng W; Cui H
Biomed Pharmacother; 2018 Jun; 102():169-174. PubMed ID: 29554595
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
[TBL] [Abstract][Full Text] [Related]
8. lncRNA SNHG1 negatively regulates miRNA‑101‑3p to enhance the expression of ROCK1 and promote cell proliferation, migration and invasion in osteosarcoma.
Deng R; Zhang J; Chen J
Int J Mol Med; 2019 Mar; 43(3):1157-1166. PubMed ID: 30592267
[TBL] [Abstract][Full Text] [Related]
9. LncRNA BLACAT1 accelerates the proliferation and migration of osteosarcoma cells through regulating STAT3.
Dong Z; Wang Y
Pathol Res Pract; 2019 Mar; 215(3):571-579. PubMed ID: 30665678
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding nature brain-derived neurotrophic factor antisense is associated with poor prognosis and functional regulation in non-small cell lung caner.
Shen M; Xu Z; Jiang K; Xu W; Chen Y; Xu Z
Tumour Biol; 2017 May; 39(5):1010428317695948. PubMed ID: 28459374
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA CTA sensitizes osteosarcoma cells to doxorubicin through inhibition of autophagy.
Wang Z; Liu Z; Wu S
Oncotarget; 2017 May; 8(19):31465-31477. PubMed ID: 28415557
[TBL] [Abstract][Full Text] [Related]
12. Long Non-Coding RNA TUG1 Promotes Proliferation and Inhibits Apoptosis of Osteosarcoma Cells by Sponging miR-132-3p and Upregulating SOX4 Expression.
Li G; Liu K; Du X
Yonsei Med J; 2018 Mar; 59(2):226-235. PubMed ID: 29436190
[TBL] [Abstract][Full Text] [Related]
13. LncRNA SNHG3 promotes cell growth by sponging miR-196a-5p and indicates the poor survival in osteosarcoma.
Chen J; Wu Z; Zhang Y
Int J Immunopathol Pharmacol; 2019; 33():2058738418820743. PubMed ID: 30791797
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA EPIC1 inhibits viability and invasion of osteosarcoma cells by promoting MEF2D ubiquitylation.
Zhao W; Zhang D; Qin P; Zhang J; Cui X; Gao J; Wang J; Li J
Int J Biol Macromol; 2019 May; 128():566-573. PubMed ID: 30703420
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of long non-coding RNA MFI2 promotes cell proliferation and suppresses apoptosis in human osteosarcoma.
Yin Z; Ding H; He E; Chen J; Li M
Oncol Rep; 2016 Oct; 36(4):2033-40. PubMed ID: 27513470
[TBL] [Abstract][Full Text] [Related]
16. LncRNA CCAT2 enhances cell proliferation via GSK3β/β-catenin signaling pathway in human osteosarcoma.
Ruan R; Zhao XL
Eur Rev Med Pharmacol Sci; 2018 May; 22(10):2978-2984. PubMed ID: 29863240
[TBL] [Abstract][Full Text] [Related]
17. LncRNA TUG1 promotes cell proliferation and suppresses apoptosis in osteosarcoma by regulating miR-212-3p/FOXA1 axis.
Xie C; Chen B; Wu B; Guo J; Cao Y
Biomed Pharmacother; 2018 Jan; 97():1645-1653. PubMed ID: 29793327
[TBL] [Abstract][Full Text] [Related]
18. A long non-coding RNA contributes to doxorubicin resistance of osteosarcoma.
Zhang CL; Zhu KP; Shen GQ; Zhu ZS
Tumour Biol; 2016 Feb; 37(2):2737-48. PubMed ID: 26408180
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of long noncoding RNA CCAL predicts poor patient prognosis and promotes tumor metastasis in osteosarcoma.
Zhou DK; Yang XW; Li H; Yang Y; Zhu ZJ; Wu N
Int J Biol Markers; 2017 Mar; 32(1):e108-e112. PubMed ID: 28009431
[TBL] [Abstract][Full Text] [Related]
20. lncRNA LINC01296 regulates the proliferation, metastasis and cell cycle of osteosarcoma through cyclin D1.
Yu X; Pang L; Yang T; Liu P
Oncol Rep; 2018 Nov; 40(5):2507-2514. PubMed ID: 30226542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
